Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Building bridges: multidisciplinary teams in tuberculosis prevention and care

João Pedro Ramos, Mariana Vieira, Cátia Pimentel, Mariana Argel, Pedro Barbosa, Raquel Duarte
Breathe 2023 19: 230092; DOI: 10.1183/20734735.0092-2023
João Pedro Ramos
1Departamento de Estudos das Populações, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.
2EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for João Pedro Ramos
Mariana Vieira
2EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cátia Pimentel
3Centro Hospitalar de Leiria, Leiria, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Argel
4Centro Hospitalar Tondela-Viseu, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariana Argel
Pedro Barbosa
2EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Duarte
1Departamento de Estudos das Populações, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.
2EPI Unit, Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal
5Unidade de Investigaçao Clínica da Administraçao Regional de Saúde do Norte, Porto, Portugal
6Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raquel Duarte
  • For correspondence: raquelafduarte@gmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

People with or affected by tuberculosis (TB) experience complex social and cultural constraints that may affect treatment outcomes by impeding access to proper care or by hindering treatment adherence. Low levels of health literacy which leads to inadequate disease information; stigma, discrimination and other forms of prejudice that may result in marginalisation and ostracisation; and socioeconomic vulnerabilities that hamper one's capacity to access essential goods or increase the risk of exposure to the disease are some of the barriers highlighted. These complex hurdles are also disproportionately felt by people with or affected by TB due to gender-related inequalities that need to be properly addressed. Additionally, TB prevention and care should encompass interventions aimed at improving and promoting mental health, given that mental unhealth may further thwart treatment adherence and success. A multifaceted and multidisciplinary approach to TB is required to answer these complex barriers.

Tweetable abstract

To effectively address the complex sociocultural and financial barriers to TB diagnosis and treatment multifaceted interventions that consider personal factors, like health literacy, and societal dimensions, like stigma and discrimination, are necessary. https://bit.ly/3Ct6tMw

Introduction

Managing tuberculosis (TB) effectively requires a multidisciplinary approach that involves professionals with different areas of expertise [1, 2]. Physicians, for one, play a crucial role, as they employ a number of resources to better and more efficiently apply the correct diagnosis. They also prescribe the appropriate anti-TB medications, monitor treatment progress and manage any side-effects or complications that may arise during the course of treatment. Nurses also play an important part in the day-to-day management of TB patients. They provide direct patient care, educate people and their families about TB, and aid in treatment adherence. Epidemiologists and public health experts are also key in TB management by tracking the spread of the disease, identifying high-risk populations, implementing screening and contact tracing programmes, and designing targeted interventions to control the spread of TB. Other healthcare professionals, such as laboratory professionals, will aid in the confirmation of the diagnosis and drug susceptibility testing, features that are important to guide treatment decisions (table 1).

View this table:
  • View inline
  • View popup
TABLE 1

Contributions of multidisciplinary professionals in tuberculosis (TB) prevention and care

Although accurate diagnosis, proper treatment and infection control are essential, they are not enough [3]. In order to improve treatment adherence and outcomes and reduce transmission of TB in communities, there is a need to involve professionals from other disciplines and civil communities, such as mental health experts or community advisors are also vital in guaranteeing the best treatment outcomes, by analysing and acting on health-related social factors that may influence treatment adherence [4, 5].

In this viewpoint, we analyse the primary challenges faced by people with and affected by TB, while exploring strategies to address them.

Complexities of sociocultural barriers

There is a significant deficit in awareness of TB signs and symptoms, as well as in the cruciality of early diagnosis and treatment. Multiple barriers have been reported, including, but not limited to, low literacy levels, stigma, inadequate knowledge of the disease and perceptions of poor quality of care in hospitals by people with TB [6]. In some cultures, TB treatment is affected by traditional and superstitious beliefs, leading to the use of traditional healers or ineffective treatments, rather than seeking medical care for a proper diagnosis [7].

Merely stating that TB is an infectious disease is often insufficient to dispel myths and superstitions that are deeply ingrained in communities [8]. To effectively address these beliefs, it may be necessary to engage influential community members, as they can play a critical role in promoting awareness and acceptance of TB treatment initiatives [8].

Health literacy is a critical factor in treatment-seeking behaviour. Individuals with low health literacy may have difficulty understanding and acting on health information, even if they have access to it. Thus, improving general awareness of hygiene and healthy behaviours is essential for both preventing and treating TB [9].

Health education plays a vital role in TB prevention and care, equipping individuals and communities with the knowledge and resources necessary to effectively prevent and treat the infection. Health professionals must recognise the cultural and social factors that affect TB treatment, such as stigma, discrimination or gender-based barriers, and take proactive measures to address them [9].

TB stigma and discrimination

People living with TB face additional, often unseen, constraints that stem from discriminatory and stigmatising beliefs and attitudes leading to marginalisation. In fact, the renewed effort to “eradicate the TB epidemic” is hampered by the pervasive stigma [10], which can be felt in a multitude of social settings (e.g. home, workplace, communities) [8] and can impede diagnosis, monitoring and treatment [11]. Stigma can jeopardise TB patients’ quality of life, harm their sense of self-worth and self-efficacy, and cause social exclusion and self-repression [12].

Interventions and challenges

Although TB stigma is an important social determinant of health [13], interventions intended to reduce it are not always implemented, evaluated or reported, or are jeopardised by poor methodological planning, implementation and assessment [14]. The general public, healthcare professionals and people with TB are the three essential populations targeted by TB stigma reduction interventions, according to Nuttal et al. [14]. These authors pointed out that none of the psychosocial interventions examined had as their primary or co-primary goal the decrease of TB stigma.

The effect of the TB infection calls for the creation of interventions that go beyond “cure” and instead prioritise mental health as a crucial component of therapeutic success. Mental health issues complicate the outcome of TB and must therefore be properly addressed through in-depth psychoeducation, psychological first aid and prompt intervention [5].

Overcoming gender-related barriers

Women face various barriers to accessing TB treatment, including financial dependence, lack of physical autonomy, stigma within their families and relatively low levels of general and TB-related literacy [15]. Women facing gender-based violence or vulnerable situations may encounter additional difficulties accessing TB treatment [15]. Addressing gender-related barriers to TB treatment requires a multifaceted approach that involves improving awareness, providing gender-sensitive care and addressing social and economic barriers [15].

Economic barriers to TB care

Socioeconomic deprivation is multifaceted and includes multiple components that lead to a lack of social and economic essentials [16]. This results in poorer living and working conditions, household overcrowding and malnutrition, which increases the risk of exposure to TB, increases vulnerability to disease and the risk of unsuccessful treatment outcome [16]. The inclusion of more immediate determinants in multiple regression models increases the understanding of the effect of poverty on TB to include multiple pathways and effects [16].

Financial toll of TB

The financial burden to patients with a TB diagnosis and the subsequent care can include medical expenses (e.g. consultation fees), non-medical expenses (e.g. transportation to healthcare facilities), and indirect costs, such as lost income due to missing days, unemployment or carer time [17]. These costs create barriers to healthcare access and treatment adherence, which in turn negatively affects treatment outcomes and perpetuates TB transmission [17]. These expenses can also adversely affect the socioeconomic condition of TB-affected households, particularly those that are already impoverished [17].

Social support has a key role to reduce this economic burden, that can be delivered according to each individual's needs, such as increasing the coverage of services related to TB or covering related comorbidities and risk factors, eliminating informal fees, exploring social protection for specific vulnerable groups or people with medical conditions, providing assistance for poor or vulnerable families, sickness or disability grants, cash or in-kind transfer programmes and specific allowances (e.g. food, transportation) [11]. Many of these initiatives will need a multidisciplinary approach, including involvement outside the health sector [18].

Collaborative action for improved health outcomes

A multidisciplinary approach enables communities affected by TB to receive comprehensive and coordinated care that addresses their medical, social and cultural needs [19]. By working together, professionals from a range of disciplines can provide effective support and assistance to key vulnerable populations, namely refugees and migrants [20, 21]. Healthcare professionals should work to ensure that these populations receive the appropriate medication, care and support, while social workers and mental health professionals can provide counselling and support services to help individuals cope with the emotional and psychological impact of TB.

Cultural mediators

Cultural mediators play a crucial role in facilitating communication between healthcare providers and vulnerable populations, particularly refugees and migrants who may have limited proficiency in the local language or cultural barriers that may prevent them from seeking healthcare services [22, 23]. By helping to bridge the cultural and linguistic divide, cultural mediators can help to ensure that these populations receive appropriate and effective healthcare services, and that healthcare providers understand their cultural, social and linguistic needs [23].

People-centred communication

Healthcare professionals must lean into high-quality, patient-centred communication, embracing patients’ concerns, and provide culturally competent care that respects their values and beliefs. Interpersonal channels such as face-to-face communication, regular interaction among healthcare workers and patients are effective methods to address the barriers presented [9]. Every professional must be equipped to address social awareness about TB, dispel myths and misconceptions, and encourage early detection and treatment as an important process in TB diagnosis and treatment [9].

Inclusive health systems and digital health technologies

One of the key recommendations to overcome these barriers and reduce TB burden, is to build more inclusive and equitable health systems (e.g. through the decentralisation of diagnosis) [24]. Primary healthcare is usually the first level of contact with medical services and should be considered the cornerstone of universal health coverage [25]. Primary healthcare can play an important role in promoting early TB detection by identifying at-risk individuals as well as improving treatment adherence through educational interventions [26]. Nevertheless, it remains essential to have experts who can assist clinicians on particularly challenging cases, greatly contributing to positive treatment outcomes and adverse event management [27, 28].

Other strategies to improve adherence include digital health technologies, such as video observed therapy, text message or phone call reminders, medication monitoring boxes and ingestible sensors [29]. These interventions are usually preferred by patients instead of the standard directly observed therapy, since they reduce costs and travel time and have been associated with treatment completion and adherence [26–29].

Conclusion

Collaborative action that engages the community, influential leaders and professionals from diverse fields of expertise is crucial for improving TB prevention and care outcomes. To effectively address the complex sociocultural and financial barriers to TB diagnosis and treatment, multifaceted interventions that consider personal factors like health literacy as well as societal dimensions like stigma and discrimination are necessary. By building bridges between different stakeholders, we can develop successful strategies to end TB and ensure access to timely and appropriate care for all.

Footnotes

  • Conflict of interest: J.P. Ramos reports grants or contracts from the Institute of Public Health of the University of Porto, Camara Municipal do Porto, Institute of Biomedical Sciences Abel Salazar, University of Porto, and Faculty of Psychology and Education Sciences of the University of Porto, outside the submitted work; and consulting fees from Núcleo de Investigação em Pneumologia, Centro Hospitalar Vila Nova Gaia/Espinho, outside the submitted work. M. Vieira ports grants or contracts from the Institute of Public Health of the University of Porto, outside the submitted work; and consulting fees from Núcleo de Investigação em Pneumologia, Centro Hospitalar Vila Nova Gaia/Espinho, outside the submitted work. P. Barbosa reports grants or contracts from the Institute of Public Health of the University of Porto, outside the submitted work; and consulting fees from Núcleo de Investigação em Pneumologia, Centro Hospitalar Vila Nova Gaia/Espinho, outside the submitted work. R. Duarte reports grants or contracts from H2020 - UNIT4TB – 101007873, and H2020 - EUSAT-RCS – 823890, outside the submitted work. The remaining authors have nothing to disclose.

  • Received April 20, 2023.
  • Accepted June 7, 2023.
  • Copyright ©ERS 2023
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Souza M,
    2. Pereira S,
    3. Marinho J, et al.
    Characteristics of healthcare services associated with adherence to tuberculosis treatment. Rev Saude Publica 2009; 43: 997–1005. doi:10.1590/S0034-89102009005000085
    OpenUrlPubMed
  2. ↵
    1. Brugueras S,
    2. Roldán L,
    3. Rodrigo T, et al.
    Organization of tuberculosis control in Spain: evaluation of a strategy aimed at promoting the accreditation of tuberculosis units. Arch Bronconeumol (Engl Ed) 2020; 56: 90–98. doi:10.1016/j.arbr.2019.12.002
    OpenUrl
  3. ↵
    1. Brewer T,
    2. Heymann S
    . To control and beyond: moving towards eliminating the global tuberculosis threat. J Epidemiol Community Health 2004; 58: 822–825. doi:10.1136/jech.2003.008664
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Hayward S,
    2. Deal A,
    3. Rustage K, et al.
    The relationship between mental health and risk of active tuberculosis: a systematic review. BMJ Open 2022; 12: e048945. doi:10.1136/bmjopen-2021-048945
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Agarwal N,
    2. Sarthi P
    . The necessity of psychological interventions to improve compliance with tuberculosis treatment and reduce psychological distress. J Family Med Prim Care 2020; 9: 4174–4180. doi:10.4103/jfmpc.jfmpc_1404_20
    OpenUrl
  6. ↵
    1. Storla DG,
    2. Yimer S,
    3. Bjune GA
    . A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8: 15. doi:10.1186/1471-2458-8-15
    OpenUrlCrossRefPubMed
  7. ↵
    1. Oga-Omenka C,
    2. Wakdet L,
    3. Menzies D, et al.
    A qualitative meta-synthesis of facilitators and barriers to tuberculosis diagnosis and treatment in Nigeria. BMC Public Health 2021; 21: 279. doi:10.1186/s12889-021-10173-5
    OpenUrl
  8. ↵
    1. Baral SC,
    2. Karki DK,
    3. Newell JN
    . Causes of stigma and discrimination associated with tuberculosis in Nepal: a qualitative study. BMC Public Health 2007; 7: 211. doi:10.1186/1471-2458-7-211
    OpenUrlCrossRefPubMed
  9. ↵
    1. Arulchelvan S,
    2. Elangovan R
    . Effective communication approaches in tuberculosis control: health workers’ perceptions and experiences. Indian J Tuberc 2017; 64: 318–322. doi:10.1016/j.ijtb.2016.11.017
    OpenUrlPubMed
  10. ↵
    1. Sommerland N,
    2. Wouters E,
    3. Mitchell EM, et al.
    Evidence-based interventions to reduce tuberculosis stigma: a systematic review. Int J Tuberc Lung Dis 2017; 21: 81–86. doi:10.5588/ijtld.16.0788
    OpenUrl
  11. ↵
    1. Nyblade L,
    2. Stockton MA,
    3. Giger K, et al.
    Stigma in health facilities: why it matters and how we can change it. BMC Med 2019; 17: 25. doi:10.1186/s12916-019-1256-2
    OpenUrlPubMed
  12. ↵
    1. Guo N,
    2. Marra F,
    3. Marra CA
    . Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes 2009; 7: 14. doi:10.1186/1477-7525-7-14
    OpenUrlCrossRefPubMed
  13. ↵
    1. Craig GM,
    2. Daftary A,
    3. Engel N, et al.
    Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. Int J Infect Dis 2017; 56: 90–100. doi:10.1016/j.ijid.2016.10.011
    OpenUrlPubMed
  14. ↵
    1. Nuttall C,
    2. Fuady A,
    3. Nuttall H, et al.
    Interventions pathways to reduce tuberculosis-related stigma: a literature review and conceptual framework. Infect Dis Poverty 2022; 11: 101. doi:10.1186/s40249-022-01021-8
    OpenUrl
  15. ↵
    1. Krishnan L,
    2. Akande T,
    3. Shankar A, et al.
    Gender-related barriers and delays in accessing tuberculosis diagnostic and treatment services: a systematic review of qualitative studies. Tuberc Res Treat 2014; 2014: 215059.
    OpenUrl
  16. ↵
    1. Duarte R,
    2. Lönnroth K,
    3. Carvalho C, et al.
    Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology 2018; 24: 115–119. doi:10.1016/j.rppnen.2017.11.003
    OpenUrlCrossRefPubMed
  17. ↵
    1. Viney K,
    2. Islam T,
    3. Hoa NB, et al.
    The financial burden of tuberculosis for patients in the western-pacific region. Trop Med Infect Dis 2019; 4: 94. doi:10.3390/tropicalmed4020094
    OpenUrl
  18. ↵
    1. Pavli A,
    2. Maltezou H
    . Health problems of newly arrived migrants and refugees in Europe. J Travel Med 2017; 24: tax016. doi:10.1093/jtm/tax016
    OpenUrl
  19. ↵
    1. Riza E,
    2. Kalkman S,
    3. Coritsidis A, et al.
    Community-based healthcare for migrants and refugees: a scoping literature review of best practices. Healthcare (Basel) 2020; 8: 115. doi:10.3390/healthcare8020115
    OpenUrl
  20. ↵
    1. Laverack G
    . The challenge of promoting the health of refugees and migrants in Europe: a review of the literature and urgent policy options. Challenges 2018; 9: 32. doi:10.3390/challe9020032
    OpenUrl
  21. ↵
    1. World Health Organization
    . The End TB Strategy. Geneva, World Health Organization, 2015. www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy
  22. ↵
    1. Kluge H,
    2. Kelley E,
    3. Barkley, S, et al.
    How primary health care can make universal health coverage a reality, ensure healthy lives, and promote wellbeing for all. Lancet 2018; 392: 1372–1374. doi:10.1016/S0140-6736(18)32482-6
    OpenUrlCrossRefPubMed
  23. ↵
    1. Sulis G,
    2. Centis R,
    3. Sotgiu, G, et al.
    Recent developments in the diagnosis and management of tuberculosis. NPJ Prim Care Respir Med 2016; 26: 16078. doi:10.1038/npjpcrm.2016.78
    OpenUrl
  24. ↵
    1. Blasi F,
    2. Dara M,
    3. van der Werf MJ, et al.
    Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur Respir J 2013; 41: 491–494. doi:10.1183/09031936.00196712
    OpenUrlFREE Full Text
  25. ↵
    1. Migliori GB,
    2. Bothamley G,
    3. Duarte R, et al.
    1. Caminero JA,
    2. Scardigli A,
    3. van der Werf T, et al.
    Treatment of drug-susceptible and drug- resistant tuberculosis. In: Migliori GB, Bothamley G, Duarte R, et al., eds. Tuberculosis (ERS Monograph). Sheffield, European Respiratory Society, 2018; pp. 152–178. doi:10.1183/2312508X.erm8218
  26. ↵
    1. Ridho A,
    2. Alfian SD,
    3. van Boven, JFM, et al.
    Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: systematic review of randomized controlled trials. J Med Internet Res 2022; 24: e33062. doi:10.2196/33062
    OpenUrlPubMed
  27. ↵
    1. Pradipta IS,
    2. Houtsma D,
    3. van Boven, JFM, et al.
    Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies. NPJ Prim Care Respir Med 2020; 30: 21. doi:10.1038/s41533-020-0179-x
    OpenUrlPubMed
  28. ↵
    1. Alipanah N,
    2. Jarlsberg L,
    3. Miller, C, et al.
    Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med 2018; 15: e1002595. doi:10.1371/journal.pmed.1002595
    OpenUrlPubMed
  29. ↵
    1. Chuck C,
    2. Robinson E,
    3. Macaraig, M, et al.
    Enhancing management of tuberculosis treatment with video directly observed therapy in New York City. Int J Tuberc Lung Dis 2016; 20: 588–593. doi:10.5588/ijtld.15.0738
    OpenUrlPubMed
PreviousNext
Back to top
Vol 19 Issue 3 Table of Contents
Breathe: 19 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Building bridges: multidisciplinary teams in tuberculosis prevention and care
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Building bridges: multidisciplinary teams in tuberculosis prevention and care
João Pedro Ramos, Mariana Vieira, Cátia Pimentel, Mariana Argel, Pedro Barbosa, Raquel Duarte
Breathe Sep 2023, 19 (3) 230092; DOI: 10.1183/20734735.0092-2023

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Building bridges: multidisciplinary teams in tuberculosis prevention and care
João Pedro Ramos, Mariana Vieira, Cátia Pimentel, Mariana Argel, Pedro Barbosa, Raquel Duarte
Breathe Sep 2023, 19 (3) 230092; DOI: 10.1183/20734735.0092-2023
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Tweetable abstract
    • Introduction
    • Complexities of sociocultural barriers
    • TB stigma and discrimination
    • Overcoming gender-related barriers
    • Economic barriers to TB care
    • Collaborative action for improved health outcomes
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The urgency of a new and improved TB vaccine and the WHO's TB vaccine accelerator council
  • Rolling out new anti-TB drugs without diagnostic capacity
Show more Viewpoint

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society